Featured Research

from universities, journals, and other organizations

Cost-savings Of Colorectal Cancer Screening As Treatment Costs Increase

Date:
September 24, 2009
Source:
Journal of the National Cancer Institute
Summary:
Investing in some colorectal cancer screening programs could cut future, more expensive treatment costs in half, according to a new study. The only screening program found not to be cost-saving was colonoscopy.

Investing in some colorectal cancer screening programs could cut future, more expensive treatment costs in half, according to a new study published online September 24 in the Journal of the National Cancer Institute. The only screening program found not to be cost-saving was colonoscopy.

Governments and insurance companies may invest more in colorectal cancer screening programs—some of which have proven to reduce colorectal cancer mortality—if the cost-savings were known, especially as more expensive cancer drugs continue to hit the market.

Iris Lansdorp-Vogelaar, Ph.D., of the Department of Public Health, Eramus MC, University Medical Center Rotterdam in the Netherlands, and colleagues used a microsimulation model, known as the MISCAN-Colon model, to assess whether the increasing use of new, very costly drugs would affect treatment savings of colorectal cancer screening.

Researchers looked at annual guaiac fecal occult blood testing (FOBT), annual immunochemical FOBT, sigmoidoscopy every 5 years, colonoscopy every 10 years, and the combination of sigmoidoscopy every 5 years and annual guaiac FOBT in the general population for three chemotherapy treatment scenarios: the past, the present, and the near future.

The treatment savings from screening were more than twice as high in the near-future scenario, which included the widespread use of expensive new chemotherapies, than in the past scenario for all test strategies. This increase in savings makes screening with all strategies except colonoscopy cost-saving, according to the authors.

"The increasingly costly management of colorectal cancer will approximately double the treatment savings from screening," the authors write. "…screening is not only desirable from the perspective of governments and insurance companies to reduce colorectal cancer incidence and mortality, but in addition will also help to contain the increasing costs for the management of colorectal cancer."


Story Source:

The above story is based on materials provided by Journal of the National Cancer Institute. Note: Materials may be edited for content and length.


Cite This Page:

Journal of the National Cancer Institute. "Cost-savings Of Colorectal Cancer Screening As Treatment Costs Increase." ScienceDaily. ScienceDaily, 24 September 2009. <www.sciencedaily.com/releases/2009/09/090924163522.htm>.
Journal of the National Cancer Institute. (2009, September 24). Cost-savings Of Colorectal Cancer Screening As Treatment Costs Increase. ScienceDaily. Retrieved October 21, 2014 from www.sciencedaily.com/releases/2009/09/090924163522.htm
Journal of the National Cancer Institute. "Cost-savings Of Colorectal Cancer Screening As Treatment Costs Increase." ScienceDaily. www.sciencedaily.com/releases/2009/09/090924163522.htm (accessed October 21, 2014).

Share This



More Health & Medicine News

Tuesday, October 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

CDC Revamps Ebola Guidelines After Criticism

CDC Revamps Ebola Guidelines After Criticism

Newsy (Oct. 21, 2014) The Centers for Disease Control and Prevention have issued new protocols for healthcare workers interacting with Ebola patients. Video provided by Newsy
Powered by NewsLook.com
WHO: Ebola Vaccine Trials to Start a in January

WHO: Ebola Vaccine Trials to Start a in January

AP (Oct. 21, 2014) Tens of thousands of doses of experimental Ebola vaccines could be available for "real-world" testing in West Africa as soon as January as long as they are deemed safe in soon to start trials, the World Health Organization said Tuesday. (Oct. 21) Video provided by AP
Powered by NewsLook.com
First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

First-Of-Its-Kind Treatment Gives Man Ability To Walk Again

Newsy (Oct. 21, 2014) A medical team has for the first time given a man the ability to walk again after transplanting cells from his brain onto his severed spinal cord. Video provided by Newsy
Powered by NewsLook.com
CDC Issues New Ebola Guidelines for Health Workers

CDC Issues New Ebola Guidelines for Health Workers

Reuters - US Online Video (Oct. 21, 2014) The U.S. Centers for Disease Control and Prevention has set up new guidelines for health workers taking care of patients infected with Ebola. Linda So reports. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins